FTT 0.00% 0.5¢ factor therapeutics limited

Procedural Mistakes or lack of public information's in reference to the EU andFDA Trial, page-3

  1. 9,595 Posts.
    lightbulb Created with Sketch. 330
    "Suppose that in the US trial has been used an expensive standard of care dressing and procedure that has a cost of $2,000-$3,000 per treatment day. Being In the high end side of treatment value, the patient will be led to have a good wound response. Now suppose the FTT application costs with Its simplicity in total $ 1,500"

    A nice try Olef, but I think it's time you let this go, and accept that we got our investment wrong. The figures looked good, so our investing was sound - it just didn't work out.

    As for vitrogrow being cheaper, well the ftt arms got vitrogro and standard care, so it's like we had a Rolls Royce with extras!

    "Treatment: Eligible patients will be assigned to one of the following treatment groups:
    • Placebo and SC
    • VF001-DP (14 micrograms per treatment) and SC (low dose [LD])
    • VF001-DP (140 micrograms per treatment) and SC (high dose [HD])."

    https://www.clinicaltrials.gov/ct2/show/NCT02973893?term=vf001&rank=1
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.